Literature DB >> 33368184

The tandem stenosis mouse model: Towards understanding, imaging, and preventing atherosclerotic plaque instability and rupture.

Jonathan Noonan1,2,3, Alex Bobik3,4,5, Karlheinz Peter1,2,3,6.   

Abstract

The rupture of unstable atherosclerotic plaques is the major cause of cardiovascular mortality and morbidity. Despite significant limitations in our understanding and ability to identify unstable plaque pathology and prevent plaque rupture, most atherosclerosis research utilises preclinical animal models exhibiting stable atherosclerosis. Here, we introduce the tandem stenosis (TS) mouse model that reflects plaque instability and rupture, as seen in patients. The TS model involves dual ligation of the right carotid artery, leading to locally predefined unstable atherosclerosis in hypercholesterolaemic mice. It exhibits key characteristics of human unstable plaques, including plaque rupture, luminal thrombosis, intraplaque haemorrhage, large necrotic cores, thin or ruptured fibrous caps and extensive immune cell accumulation. Altogether, the TS model represents an ideal preclinical tool for improving our understanding of human plaque instability and rupture, for the development of imaging technologies to identify unstable plaques, and for the development and testing of plaque-stabilising treatments for the prevention of atherosclerotic plaque rupture. LINKED ARTICLES: This article is part of a themed issue on Preclinical Models for Cardiovascular disease research (BJP 75th Anniversary). To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.5/issuetoc.
© 2020 The British Pharmacological Society.

Entities:  

Keywords:  atherosclerosis; drug discovery/target validation; imaging; in vivo; inflammation

Mesh:

Year:  2021        PMID: 33368184     DOI: 10.1111/bph.15356

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  5 in total

1.  Proposed protocol for the investigation of the safety and efficacy of the COVID-19 vaccine for patients with psychosis, with pilot safety findings from a Chinese psychiatrist's self-experiment.

Authors:  Chongguang Lin; Tao Fang; Jiayue Chen; Qianchen Li; Weiliang Yang; Cong Yao; Lina Wang; Yun Sun; Ziyao Cai; Jing Ping; Ce Chen; Langlang Cheng; Jinjing Zhu; Guangdong Chen; Peiwei Shan; Chunmian Chen; Xiaodong Lin; Hongjun Tian; Chuanjun Zhuo
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

Review 2.  Atherosclerosis: Recent developments.

Authors:  Johan L M Björkegren; Aldons J Lusis
Journal:  Cell       Date:  2022-05-02       Impact factor: 66.850

3.  Pharmacological Inhibition of Factor XIIa Attenuates Abdominal Aortic Aneurysm, Reduces Atherosclerosis, and Stabilizes Atherosclerotic Plaques.

Authors:  Amy K Searle; Yung-Chih Chen; Maria Wallert; Xiaowei Wang; Hamid Hosseini; Karlheinz Peter; James D McFadyen; Ana C Maluenda; Jonathan Noonan; Peter Kanellakis; Maria T K Zaldivia; Angela Huang; Hadi Lioe; Mark Biondo; Marc W Nolte; Paolo Rossato; Alex Bobik; Con Panousis
Journal:  Thromb Haemost       Date:  2022-01-21       Impact factor: 6.681

4.  Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor Dapagliflozin Stabilizes Diabetes-Induced Atherosclerotic Plaque Instability.

Authors:  Yung-Chih Chen; Karin Jandeleit-Dahm; Karlheinz Peter
Journal:  J Am Heart Assoc       Date:  2021-12-31       Impact factor: 6.106

5.  Identification of core genes associated with the anti-atherosclerotic effects of Salvianolic acid B and immune cell infiltration characteristics using bioinformatics analysis.

Authors:  Zheng Jin; Huanyi Zhao; Yuan Luo; Xiushen Li; Jiayan Cui; Jing Yan; Pingzhen Yang
Journal:  BMC Complement Med Ther       Date:  2022-07-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.